Download our whitepaper,
Breast Cancer Clinical Trials:
Designing Studies for Efficacy and
Precision
What's Inside:
- Hormone receptor and HER2 status-driven trial designs.
- Endpoints: pathologic complete response and disease-free survival.
- Neoadjuvant and adjuvant therapy trial strategies.
- Immunotherapy and targeted drug evaluation.
- Patient-reported outcomes and quality-of-life measures.
- Regulatory trends shaping breast cancer trial approvals.
Access your complimentary whitepaper today:
Breast Cancer
Breast cancer is a chronic and often life-threatening disease characterized by the uncontrolled growth of breast cells. It is one of the most common cancers among women worldwide, but it can also affect men.
In recent years, research has significantly advanced our understanding of breast cancer, uncovering its multifaceted nature involving genetic mutations, hormonal influences, and lifestyle and environmental factors.
This evolving knowledge has been crucial in developing current therapeutic strategies that target specific genetic mutations, utilize hormone therapy, and incorporate lifestyle and environmental management.
iNGENū’s team of experienced researchers and clinicians specializes in designing and conducting innovative studies. Leveraging enhanced trial design and comprehensive patient-centric strategies, we are committed to accelerating the development of new treatments for breast cancer.
Breast cancer accounts for
25%
of cancer cases in women
Women have a
12.5%
chance of developing breast cancer in their life
The 5-year relative survival rate for localized breast cancer is about
99%
Our clinical team has over
120
years of combined clinical trial experience